References
- Weycker D, Farkouh RA, Strutton DR, Edelsberg J, Shea KM, Pelton SI. Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Serv Res. 2016;16(1):182. doi:10.1186/s12913-016-1432-4.
- Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61(40):816–19. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6140a4.htm.
- Chapter 4: other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Disease Initiative Global Outcomes (KDIGO). Kidney Int Suppl. 2013;3(1):91–111. 2011. doi:10.1038/kisup.2012.67.
- Grupo de trabajo vacunación en población adulta y grupos de riesgo de la Ponencia de Programa y Registro de Vacunaciones. Vacunación en grupos de riesgo de todas las edades y en determinadas situaciones. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, julio 2018 [accessed 2018 Nov 29]. http://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/VacGruposRiesgo/Vac_GruposRiesgo_todasEdades.htm.
- Shen AK, Kelman JA, Warnock R, Zhang W, Brereton S, McKean S, Wernecke M, Chu S, Gellin BG. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015. Vaccine. 2017;35(52):7302–08. doi:10.1016/j.vaccine.2017.10.105.
- Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS One. 2012;7(11):e50553. doi:10.1371/journal.pone.0050553.
- Wilmore SM, Philip KE, Cambiano V, Bretherton CP, Harborne JE, Sharma A, Jayasena SD. Influenza and pneumococcal vaccinations in dialysis patients in a London district general hospital. Clin Kidney J. 2014;7(1):27–32. doi:10.1093/ckj/sft138.
- Schmedt N, Schiffner-Rohe J, Sprenger R, Walker J, von Eiff C, Häckl D. Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany. PLoS One. 2019;14(8):e0220848. doi:10.1371/journal.pone.0220848.
- Rivera Casares F, Pineda Coronel R, García de León Chocano S., López S., Montagud S., Lorente P. Vaccination status of immunocompromised patients attended in primary care. Gac Sanit. 2015;29(3):235–36. doi:10.1016/j.gaceta.2014.12.002.
- Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson DE, Finkelstein J. The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc. 2006;13(1):16–23. doi:10.1197/jamia.M1749.
- Grupo de trabajo vacunación frente a neumococo en grupos de riesgo 2015 de la Ponencia de Programas y Registro de Vacunaciones. Utilización de la vacuna frente a neumococo en grupos de riesgo. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, mayo 2015 [accessed 2015 Dec 16]. http://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/Neumococo_Gruposriesgo.pdf.
- Duval L, George C, Hedrick N, Woodruff S, Kleinpeter MA. Network 13 partnership to improve the influenza, pneumococcal pneumonia, and hepatitis B vaccination rates among dialysis patients. Adv Perit Dial. 2011;27:106–11. PMID: 22073840.
- Kasper AK, Pallotta AM, Kovacs CS, Spinner ML. Infectious diseases consult improves vaccination adherence in kidney transplant candidates. Vaccine. 2018;36(34):5112–15. doi:10.1016/j.vaccine.2018.06.058.
- Fernández-Prada M, Madroñal-Menéndez J, Martínez-Ortega C, Ramos-Martín P, Fernández-Noval F, Huerta-González I, Llorente-Pendás JL, Gómez-Martínez JR. Evaluation of vaccination coverage in cochlear implant patients at a referral hospital in Northern Spain. Acta Otorrinolaringol Esp. 2019;70(6):336–41. doi:10.1016/j.otorri.2018.08.001.
- Hernández-García I, Chaure-Pardos A, Moliner-Lahoz J, Prieto-Andrés P, Mareca-Doñate R, Giménez-Júlvez T, López-Mendoza H, García-Montero JI, Aibar-Remón C. Absenteeism and associated factors in scheduled visits to a Preventive Medicine outpatient clinic. J Healthc Qual Res. 2018;33(2):82–87. doi:10.1016/j.cali.2017.12.006.